CD8A and cancer: The ACK1 kinase not only suppressed T-cell activation but also a key chemokine, CXCL10 (Fig. 7a–c), which plays a crucial role in directing the migratory properties and potentiation of CD4+ and CD8+ T cells in the context of cancer and inflammatory autoimmunity61.